These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29217773)

  • 1. A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models.
    Krishnan N; Konidaris KF; Gasser G; Tonks NK
    J Biol Chem; 2018 Feb; 293(5):1517-1525. PubMed ID: 29217773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
    Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
    Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.
    Ito Y; Fukui M; Kanda M; Morishita K; Shoji Y; Kitao T; Hinoi E; Shirahase H
    J Pharmacol Sci; 2018 May; 137(1):38-46. PubMed ID: 29731242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
    Wang C; Wang L; Yang Z
    Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
    Zhang S; Zhang ZY
    Drug Discov Today; 2007 May; 12(9-10):373-81. PubMed ID: 17467573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.
    Qin Z; Pandey NR; Zhou X; Stewart CA; Hari A; Huang H; Stewart AF; Brunel JM; Chen HH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):21-7. PubMed ID: 25623533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization and biological activity of new 4-oxo-1,4-dihydrocinnoline-based inhibitors of the tyrosine phosphatase PTP1B and TCPTP].
    Derkach KV; Zakharova IO; Bakhtyukov AA; Sorokoumov VN; Kuznetsova VS; Shpakov AO
    Biomed Khim; 2022 Dec; 68(6):427-436. PubMed ID: 36573409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
    Nandi S; Saxena M
    Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice.
    Lantz KA; Hart SG; Planey SL; Roitman MF; Ruiz-White IA; Wolfe HR; McLane MP
    Obesity (Silver Spring); 2010 Aug; 18(8):1516-23. PubMed ID: 20075852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes.
    Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z
    Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
    Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
    J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
    Cho H
    Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 147 Kampo prescriptions as novel protein tyrosine phosphatase 1B (PTP1B) inhibitory agents.
    Onoda T; Li W; Higai K; Koike K
    BMC Complement Altern Med; 2014 Feb; 14():64. PubMed ID: 24555682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting protein tyrosine phosphatase to enhance insulin action for the potential treatment of diabetes.
    Kasibhatla B; Wos J; Peters KG
    Curr Opin Investig Drugs; 2007 Oct; 8(10):805-13. PubMed ID: 17907056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
    Zhang ZY; Lee SY
    Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazoles as novel protein tyrosine phosphatase 1B (PTP1B) inhibitors: An in vitro and in silico study.
    Rocha S; Lucas M; Silva VLM; Gomes PMO; Silva AMS; Araújo AN; Aniceto N; Guedes RC; Corvo ML; Fernandes E; Freitas M
    Int J Biol Macromol; 2021 Jun; 181():1171-1182. PubMed ID: 33857515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of licorice flavonoids as protein tyrosine phosphatase 1B inhibitors.
    Li W; Li S; Higai K; Sasaki T; Asada Y; Ohshima S; Koike K
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5836-9. PubMed ID: 24047800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development.
    Krishnan N; Bonham CA; Rus IA; Shrestha OK; Gauss CM; Haque A; Tocilj A; Joshua-Tor L; Tonks NK
    Nat Commun; 2018 Jan; 9(1):283. PubMed ID: 29348454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.